Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Advanced Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
HS-IT101 Injection for Advanced NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
SSGJ-707 in Advanced Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC
- Status
- RECRUITING
- Phase
- PHASE1
Pharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic Function
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance： a Phase II Clinical Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 Mutation
- Status
- AVAILABLE
- Phase
- N/A
Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1